Cargando…

A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials

BACKGROUND: The past few decades have seen remarkable developments in dose-finding designs for phase I cancer clinical trials. While many of these designs rely on a binary toxicity response, there is an increasing focus on leveraging continuous toxicity responses. A continuous toxicity response pert...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Se Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664620/
https://www.ncbi.nlm.nih.gov/pubmed/37990281
http://dx.doi.org/10.1186/s13063-023-07793-0